Skip to main content
News Tag: news
FORTE Study Updates: March 2025
Read More
Testing ctDNA as a Biomarker for Adjuvant Therapy Intensity in Colon Cancer (NRG-GI008, “CIRCULATE-NORTH AMERICA” Study)
Read More
NRG Oncology Trial Supports Radiotherapy Alone Following Radical Hysterectomy Should Remain the Standard of Care for Early-Stage, Intermediate-Risk Cervical Cancer
Read More
A Message from the NCTN Group Chairs: An Emphasis on the Importance of Research Funding
Read More
NRG Oncology names Dr. Charles Geyer as Associate Group Chair
Read More
Radiotherapy with Cetuximab may be superior to radiotherapy alone for selected patients who underwent surgery for head and neck cancer
Read More
Patient Reported Outcomes – Compliance Improvement Semi-Annual Recognition
Read More
NRG-BR008/The HERO Trial: Amendment Update
Read More
Adding Cemiplimab to Surgery and Radiation for Advanced Skin Cancer (NRG-HN014)
Read More
Adding BMX-001 to the Usual Chemoradiation Therapy for Patients with Head and Neck Cancer (NRG-CC013)
Read More